A Placebo-controlled Double-blind Single and Repeated Ascending Dose Study to Investigate the Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers.

Trial Profile

A Placebo-controlled Double-blind Single and Repeated Ascending Dose Study to Investigate the Safety and Tolerability of Inhaled CHF 6001 in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Sep 2013

At a glance

  • Drugs CHF 6001 (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Chiesi Farmaceutici SpA
  • Most Recent Events

    • 08 Sep 2013 Results presented at the 23rd Annual Congress of the European Respiratory Society.
    • 18 Oct 2012 New trial record
    • 16 Oct 2012 Results reported in a Chiesi media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top